(Q53886209)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351976%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Coexpression of p53 protein and MDR functional phenotype in leukemias: the predominant association in chronic myeloid leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351976%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

main subject

chronic myeloid leukemia

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351976%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Claudete Esteves Klumb

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351976%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Raquel Ciuvalschi Maia

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351976%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Geraldo Barroso Cavalcanti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351976%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Giselle Pinto de Faria

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351976%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Marcos Antônio Maurício Scheiner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351976%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Jane de Almeida Dobbin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351976%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 September 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351976%20AND%20SRC:MED&resulttype=core&format=json

Cytometry Part B: Clinical Cytometry

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351976%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351976%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351976%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

1-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351976%20AND%20SRC:MED&resulttype=core&format=json

Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 protein expression in high-grade non-Hodgkin's lymphoma.

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

Multidrug resistance in tumour cells: characterization of the multidrug resistant cell line K562-Lucena 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

Novel mechanisms of drug resistance in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

Biology of the multidrug resistance-associated protein, MRP.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

MDR1 and MRP expression in chronic B-cell lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

Expression of the multidrug transporter P-glycoprotein is highly correlated with clinical outcome in childhood acute lymphoblastic leukemia: results of a long-term prospective study.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

Expression of the multidrug resistance-associated protein in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

Multidrug resistance (MDR-1) expression in AIDS-related lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

Cancer chemoresistance: the relationship between p53 and multidrug transporters

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

Modulation of MDR/MRP by wild-type and mutant p53.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

Assessing TP53 status in human tumours to evaluate clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

Flow cytometric examination of p53 protein in primary tumors and metastases to the liver and lymph nodes of colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

DNA sequence profile of TP53 gene mutations in childhood B-cell non-Hodgkin's lymphomas: prognostic implications

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

p53 Website and analysis of p53 gene mutations in human cancer: Forging a link between epidemiology and carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

The challenge of p53 as prognostic and predictive factor in Hodgkin's or non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

Demonstration of cytoplasmic and nuclear antigens in acute leukaemia using flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

CPT-11-induced cell death in leukemic cells is not affected by the MDR phenotype.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

Comparison of anti-p53 antibodies in immunoblotting

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

MBR rearrangement and P-glycoprotein expression are not independent prognostic factors like p53 protein in malignant lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

The clinical significance of mutations of the P53 tumour suppressor gene in haematological malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): role for a p53 exon 7 gene mutation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: results of a 6-year prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

High multidrug resistance protein activity in acute myeloid leukaemias is associated with poor response to chemotherapy and reduced patient survival

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

The co-expression of p53 protein and P-glycoprotein is correlated to a poor prognosis in osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

STI571 as a targeted therapy for CML.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021

MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20013

7 January 2021